Tagayan, Nor-aiza U.

HRN: 01-70-80  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/22/2025
AMPICILLIN 1GM (VIAL)
09/22/2025
09/24/2025
IVTT
2g
Q6hours
Thinly MSAF
Waiting Final Action 
09/25/2025
CO-AMOXICLAV 625MG (TAB)
09/25/2025
10/01/2025
PO
625mg
BID
Sp 1 LTCS
Checking Initial Appropriateness 
09/26/2025
MUPIROCIN 2%, 15G (TUBE)
09/26/2025
10/02/2025
TOPICAL
1ml
OD
SP CS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: